KENNETH B LEE JR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KENNETH B LEE JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KENNETH B LEE JR. KENNETH B LEE JR is a Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in ABGENIX INC ($ABGX) and a Director in POZEN INC /NC ($POZN) and a Director in Aralez Pharmaceuticals Inc. ($ARLZ) and a Director in EYENOVIA, INC. ($EYEN).
Companies in which KENNETH B LEE JR is an Insider
ABGENIX INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KENNETH B LEE JR: Director
Holdings: 0 shares
Latest Transaction: Jun 08 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of KENNETH B LEE JR: Director
Holdings: 15,252 shares
Current Value: $86,479
Latest Transaction: May 14 2020
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EYENOVIA, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH B LEE JR: Director
Holdings: 19,359 shares
Latest Transaction: Sep 15 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Old API Wind-down Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH B LEE JR: Director
Holdings: 102,952 shares
Current Value: $431,369
Latest Transaction: May 12 2017
$ARLZ Market Capitalization: $270.87M
$ARLZ Previous Close: $4.19
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
POZEN INC /NC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH B LEE JR: Director
Holdings: 72,966 shares
Latest Transaction: Jun 25 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of KENNETH B LEE JR
Sentiment: All, ABGX, BCRX, EYEN, ARLZ, POZN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15 2020 | EYEN | EYENOVIA, INC. | LEE KENNETH B JR | Director | Option Exercise | A | 3.43 | 9,820 | 33,683 | 9,820 | |
| Sep 15 2020 | EYEN | EYENOVIA, INC. | LEE KENNETH B JR | Director | Grant | A | 0.00 | 7,288 | 0 | 19,359 | 12.1 K to 19.4 K (+60.38 %) |
| May 14 2020 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Option Exercise | A | 5.41 | 40,000 | 216,400 | 40,000 | |
| Nov 18 2019 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Buy | P | 1.45 | 5,000 | 7,250 | 15,252 | 10.3 K to 15.3 K (+48.77 %) |
| Aug 20 2019 | EYEN | EYENOVIA, INC. | LEE KENNETH B JR | Director | Option Exercise | A | 3.11 | 9,057 | 28,167 | 9,057 | |
| Aug 20 2019 | EYEN | EYENOVIA, INC. | LEE KENNETH B JR | Director | Grant | A | 0.00 | 8,038 | 0 | 12,071 | 4 K to 12.1 K (+199.31 %) |
| May 31 2019 | BCRX | BIOCRYST PHARMACEU ... | LEE KENNETH B JR | Director | Option Exercise | A | 2.91 | 30,000 | 87,300 | 30,000 |